-induced heart failure
1-alkyl-2-acetyl-sn-glycerol choline
28-day mortality
30-day readmission
8-fluo-camp binding
abc2
abcd
abdominal problems
abnormal cardiac t2
abnormal hr variability
abnormal liver texture
abnormal scn5a
absorption function
accessory pathways
accountable
accounting
acetylcholinesterase inhibitor pyridostigmine
acid
acquired heart failure
actin cytoskeleton pathways
activated neurohormonal systems
activators
active
active treatment
activities
activity
actrn
acute anthracycline-induced cardiotoxicity
acute autonomic nervous system modulation
acute care hospital
acute care hospitals
acute decompensated hf
acute heart failure trials
acute hf trials
acute pulmonary embolism
acute rv decompensation
acute treatment of heart failure
acute β-ar stimulation
ad-c
ad-c rats
ad-flk
ad-flk rats
adenoviral vector
adherence
adjunctive treatment
adjusted hazard ratio
administration
administration of contrast agent
administrative
administrative databases
admission median bnp levels
admission to discharge
advanced heart failure
advanced heart failure therapy
adverse cardiovascular
adverse event profile
adverse event rates
adverse neurohormonal activation
aerobic
aerobic capacity
aerobic exercise
aerobic exercise training
aerobic training
af type
af-free probability
affairs
afterload burden
age-by-lvef
age-dependent effect
aging
aim
air pollution
akt
albumin level
albumin levels
alcohol
aldactone evaluation study
aldosterone antagonist eplerenone
aldosterone antagonist therapy
allopurinol rats
alphalisa immunoassays
altered expression
altered protein kinase
altered ventricular structure
am
ambient air pollution
ambulatory heart failure trial
ambulatory hf
ambulatory icd patients
ambulatory patients
amyloidotic pattern
anabolic imbalance
anesthetized dogs
ang ii infusion mouse model
angeli
angiogenes
angion-receptor blocker
angiotensin converting enzyme inhibitors intolerance
angiotensin ii infusion
angiotensin receptor
angiotensin receptor antagonist valsartan
angiotensin receptor blockers therapy
animals
ann arbor veterans
annular size reduction
ans
ans mice
anterior descending
anterior leaflet opening
anthracycline exposure
anthracycline metabolism
anthracycline-containing chemotherapy
anthracycline-related congestive heart failure
anthracycline-treated breast cancer
anti-inflammatory effects
antiarrhythmic medication
antirheumatic drug
antitumor activity
anxiety
aortic blood flow
aortic pressure curve
aortic valve insufficient
aortic valve oversewing
aortic valve procedures
aortic valve repairs
aortic valve replacement
aortic valve surgery
apical rotation
arg16
arg83gly
aric hf
aric hf model
arn
arrhythmia events
arrhythmia substrate
arrhythmia-related costs
art failure
arterial compliance
artificial pulse
atheromatous coronary disease
atp demand
atp production rates
atpase activity
atrial explant-derived c-kit
atrial structure
atropine infusion
autonomic nervous system activity
autopsy
axis
b
b treatment
b-treated
b-type natriuretic peptide levels
band of activated caspase
baroreflex activity therapy
barriers to exercise
basal
basal contractility
basal rotations
baseline covariates
baseline echocardiography
baseline electrocardiogram
baseline sst2 status
bb dose
bb therapy
bcl-2 mrna expression
bcl-2 proteins
bcl-2/bax
beagle dogs
beat-to-beat qt interval
beat-to-beat qt intervals
behavioural-change interventions
bem
bem-crt
benefits
bet inhibition
beta-blocker dose
beta-blocker hypo-response
beta-blocker therapy
beta-dependent yield
bhlh transcription factor
binding
bioinformatic
biological
biomarker studies
biomarker-guided clinical trial design
biomarker-guided trials
biomedical reasons
biomedical treatment
black
black ethnicity
black race
blacks
blinded core laboratory
blinded outcome assessment trial
blockade
blocked phenylephrine-mediated hypertrophy
blood loss
blood pressure control
blood testing
blood work
blood-flow paths
blunted cardiac β-ar responsiveness
blunts
bmi-matched
bn
bnp levels
bnp measurements
body
body composition
body fat distribution
body mass
body weight
bone morphogenetic protein
borderline
both geometry
bottleneck
bottleneck stent model
bottleneck stenting covering
br4
bradycardia induced
bradycardic response
breakdown
breath-holding
breathing control
bridge to recovery
bridging therapy
bromodomain inhibition halts
bt
budget
burden of heart failure hospitalizations
c-kit
c-kit+ cell phenotype
c-kt
c57b
cab
calf muscle
caloric restriction
camp hydrolytic activity
camp levels
camp production
camp-dependent protein kinase
campbell
cancer
cancers
canine electromechanics
canine model
cardiac autonomic balance
cardiac benign tumors
cardiac biology
cardiac c-kt
cardiac centre
cardiac diameters
cardiac explant
cardiac explant-derived cells
cardiac gene control
cardiac gene therapy
cardiac genes
cardiac hypertrophic response
cardiac hypertrophy secondary to pressure-overload
cardiac insulin-resistance
cardiac l-type channel activity
cardiac magnetic resonance postcontrast
cardiac magnetic resonance t1
cardiac mena deletion
cardiac mrna levels
cardiac myocyte-specific mena overexpression
cardiac nurse
cardiac nurses
cardiac pathogenesis
cardiac pathology
cardiac pathophysiology
cardiac patients
cardiac performance
cardiac plasma membrane levels
cardiac procedures
cardiac risk
cardiac specialty hospital
cardiac surgery
cardiac sympathetic tone
cardiac sympathovagal balance
cardiac symptoms
cardiac tissue
cardiac tissues
cardiac transplant recipients
cardiac vagal
cardiac vagal tone
cardiologist
cardiology practices
cardiology services
cardiomyocyte-like cells
cardiomyopathic restriction
cardiomyopathy origin
cardiomyopathy questionnaire
cardioprotective effect
cardiopulmonary exercise variables
cardiovascular complications
cardiovascular conditions
cardiovascular event rate
cardiovascular event-free rate
cardiovascular health
cardiovascular hospitalization
cardiovascular outcomes
cardiovascular risk factors
cardiovascular surgeons
cardiovascular system
care
care management
care packages
carotid bodies
case-control study
catalytic
catecholamine infusions
catheter system
catheter-based percutaneous revascularization
catheter-based revascularization
cd hf
cd133
cd34
cdp choline
cell differentiation
cell expansion protocols
cell yield
cells isolated
cellular responses
centers for medicare and medicaid
central glycosylated
central pattern generator
centrimag rvad
cerebral blood flow
cf lvad
cgm
cha2s2vasc score
chagas
change
changes
charm programme
chelation choices
chelation regimes
chemical instability
chemotherapy-induced heart failure
chest radiation
chf predictive model
chf-developed infarcted animals
chf-dnx
chf-inv
chf-inv group
chf-inv rabbits
chf-nx
childhood malignant disease
children
chm
cholinephosphotransferase
chromatin-dependent signal transduction
chromatin-mediated signal transduction
chronic disease
chronic heart failure induced
chronic hf-ref
chronic hff
chronic inflammatory state
chronic insulin exposure
chronic kidney disease epidemiology
chronic stable guideline-directed medical therapy
chronic β-ar stimulation
circulating
circulating fragments
circulating mediator of insulin resistance
circulating nt-probnp
circulating plasma
circulatory derangement
circumferential shortening
class ii heart failure
clin
clinical care
clinical care delivery
clinical change
clinical composite response
clinical diastolic dysfunction
clinical doppler echocardiography
clinical modification codes
clinical practice
clinical prediction rule
clinical status
clinical studies
clinical trial
clinical trial registries
clinical trials
clinical variables
clinician expertise
clnka
clnka gg
clnka polymorphism
clnka snp
closure
cm
cms metric
co correlated
co-activating transcription factor networks
co-morbidity burden
cochrane effective practice
cogeneration of nitrite
cognitive function
cognitive impairment
collagen density
collected
colon
competitive
computing readmissions
concurrent hf
conditional gene-targeted hand2
conduction abnormalities
confidence scale
congenital abnormalities
congenital heart lesions
congenital lesions
congestion-like symptoms
congestive heart failure exacerbation
congestive heart failure phenotypes
congestive heart failure trial
congestive symptoms
connected elevated resistin levels
conscious dogs
conservation
consumption rate
contact
content-driven telehealth technology
contrast agent
control group
coordinate dna
cornerstone of heart failure
corporeal membrane oxygenation
corruption
cost
cost-effective
cost-effectiveness
cost-effectiveness limits
cost-effectiveness model
cost-effectiveness ratios
cost-minimization
costs
counterbalance
coupling
cox proportional hazard
cox proportional hazards
cp
cp-recommended pharmacological treatment
cps
creatine kinase activity
crf distribution
cronbach
cross-sectional
crt implantation
crt off
crt on
crt response
crude rr
cultured cardiomyocytes
cumulative administration
cumulative urine volume
currents
curve
cutoff
cutoff level
cutoff value
cv events
cytotoxic effect
danish heart failure database
dapc protein levels
debilitating stroke
decisions
decongestion
decoy
defects
defense mechanism
defibrillator-only therapy
deficits
delayed rhythm control
dementia
department of cardiology
depressed left ventricular
depression
depressive symptoms
derivation cohort
desensitization
desensitizes
detergent
developmental chromatin remodeling
device
device implantation
device therapies
devices
dgs
diabetic zsf1 rats
diagnostic procedure
diagnostic procedures
diagnostic test
dialysis-dependent patients
diastolic indices
diastolic properties
died
diet
diet adherence
diet group
diet score
diet scores
dietary
dietary patterns
dietary sodium restriction
differential g-protein coupling
diffuse myocardial changes
dilated poorly contracting ventricles
direct observation
direct renin inhibitors
discharged alive
discharged patients
discrimination
discrimination improvement
disease groups
disease management
disease management programs
disease progression
disease recapitulates
distressing implantable cardioverter-defibrillator shocks
disturbed intestinal barrier
dithiothreitol
diuretic effect
diuretic efficacy
diuretic refractory severe-end-stage hf
diuretic resistant volume overload
diuretic response
diuretic therapy
dm
dogs
dose-related gradient
double mutant
double-knockout
downstream
downward regression line shift
doxorubicin-induced heart failure
dp-4
dp-4 inhibitors
driveline infection
driveline injury
driven
drs deciles
drs-stratified hazard ratios
drug abrogated
drug dose
drug-free
dyn
dynamic
dynamic resistance training
e
e-elateral
e-emean
e-eseptal
e-lateral
e-septal correlated
early diastolic mitral annular velocity
early diastolic mitral annulus velocity
early rhythm control therapy
early transmitral blood flow velocity
early transmitral flow
early-activated septum
early-onset
early-onset hf
ec coupling gain
eccentric
echo-doppler studies
echocardiographic assessment
echocardiographic evaluations
echocardiographic evidence
echocardiographic examination
echocardiographic measurements
echocardiographic measures
echocardiographic outcomes
echocardiographic predictors
echocardiographic score
echocardiographic systolic parameters
echodiographic measures
ecmo group
ecmo+vad groups
economic
economic climate
economic evaluations
economic impact
economic models
economic savings
ect
ed cases
egf
egfr group
ejection
ejection fraction outcomes
elastic n2bus segment
electric remodeling
electrical activation
electrical activation sequence
electrocardiographic device
electromechanical behavior
electronic databases
elevated left atrial pressure
elevated resistin
elicited
embryonic gene programs
embryonic kidney
emd prolongation
emergency cardiac catheterization
emergency room practice
emotional status
emotional stress
empirically
end point of death
end stage
end-diastolic area
end-diastolic dimension
end-of-life treatment preferences
end-stage congestive heart failure
end-tidal co2
endothelial repair
endothelial-protective effects
energy deficit
energy expenditure
enhanced catabolism
enos-ser
enos-thr
enrolled
enrollment
environment
epigenetic changes
epigenetic readers
equipotent dosages
er kinase
erasers
erc induced recovery
erd
erk
erk1/2 signalling
erythropoiesis-stimulating agent therapy
et
ethically
ethnic groups
event rate
events
evidence
evidence based practice
evidence gaps
evidence points
evidence-based medications
evidence-based practices
evidence-based therapies
evidence-based treatments
exchange malfunctioning heartmate
excised
exercise
exercise adherence
exercise group
exercise performance
exercise protocol
exercise time
exercise training
exercise-induced
exogenous variants induced
expenditure
expenditures
explant-derived progenitor cells
expression of pluripotency markers
extracorporeal
extracorporeal membrane oxygenation membrane
factorial trial
factors
failing heart
failing hearts
failure of cardiovascular reserve
families
fat
fat loss
fat mass index
fat-free mass index
fatigue
fee-for-service
fes group
fetal gene
ff
fg
fiber
figure
financial
financial burden
financial costs
financials
first-in-man evidence
fish
fit
fixed ring size
fixed-rate atrial pacing
flow
flow-mediated dilatation diameter
fluorescence resonance energy transfer-based assays
flutter
follow-up echocardiograms
follow-up exercise capacity
follow-up measurement
follow-up tests
follow-up visits
font failure
force
forkhead box
foundation of management
fpassive-sarcomere length relations
free wall
free-breathing pulse sequence
full-length scn5a
function enrichment
functional abnormalities
functional class iii hf
functional class ranking
functional decline
functional deficits
functional etiology
fundamental mechanism of cardiac dysfunction
furosemide dose
futility
g-protein-coupled receptor kinase-2
gating movement
gdm-treated nyha
gem
gene expression profiling
general hospital
general linear models
genes coding
genetic susceptibility
ghg
ghm
ghs
ght
gln27
global longitudinal strain
global proteomics
glucose transporter
gly16
grading of recommendations assessment and evaluation
gross national income per capita
grounded theory
growth
gtpase rac1
guideline
guideline-heart failure registry
guideline-recommended medications
guideline-recommended treatment
guidelines-heart failure
guiding exercise rehabilitation
habc battery score
habc battery scores
haematopoetic cell transplantation
haemodynamic outcomes
haemodynamic stress
hand grip strength
hawt
hawt battery
hdl function
hdl particles
hdl-bound malondialdehyde
hdl-induced
hdl-induced no production
hdl-mediated protective effects
hdl-mediated vascular effects
health abc
health behaviors
health care expenditures
health care providers
health care system
health care systems
health initiative
health insurance
health insurance board
health outcomes
health per capita
health service planning
health service provision
health status
health system
health systems
health-care budget
healthcare common procedure
heart failure admission
heart failure admissions
heart failure care
heart failure clinic
heart failure discharges
heart failure disease
heart failure disease management
heart failure efficacy
heart failure home
heart failure mortality
heart failure patients
heart failure questionnaire
heart failure rats
heart failure-related hospitalization
heart failure-related mortality
heart failure-related qol
heart pathology
heart rate response
heart rate variation
heart t2
heart team
heart transplant recipients
heart-specific irs1
heartmate ii devices
heartmate ii exchange
heartmate ii implantation
heartmate ii lvad
heartware intl
heartware patients
hemodynamic alterations
hemodynamic disorder
hemodynamic perturbations
hemodynamic status
hemodynamically stable
hemodynamically unstable
hemoglobin levels
hemolysis events
hepatic function
herbal medicine
hf admissions
hf cases
hf clinic
hf cpgs
hf epidemiology
hf evolution
hf hospitalization
hf induced
hf model
hf mortality
hf mortality risk
hf pathogenesis
hf pathophysiology
hf prediction model
hf progression
hf ratio
hf rats
hf readmissions
hf registry
hf remodeling
hf risk factors
hf risk prediction
hf units
hf volume management
hf-action cohort
hf-induced remodeling
hf-related cachexia
hf-related morbidity
hfe
hff
hfpsi model
hfvt
hg
hg β coefficient
hgb level
hhf
high-dose bb
high-fat diet
high-frequency
high-sensitivity assay
high-volume ed cases
high-volume eds
histologic
hnorm
hnorm group
hnorm groups
home telemonitoring
horizontal longitudinal strain
hospital admission
hospital admissions
hospital claims
hospital days
hospital discharge
hospital length of stay
hospital mortality
hospital quality improvement
hospital quality of care outcomes
hospital rankings
hospital rates
hospital stay
hospitalized heart failure
hospitalized hf
hospitalized older adults
hospitalized patients
hr dynamics
hretn
hum-retn mice
human heart failure
human hf
human rad q66p
human resistin
humoral stimuli
hybrid system
hypertrophied heart
i-meta-iodobenzylguanidine
i-mib
i-mibg
i2
icd-hf
icu admission
idiopathic dilated cardiomyopathy cohort
if inhibitor ivabradine trial
il6)
imaging techniques
immunoreactive nt-probnp
impact of frailty
impaired cardiac energy metabolism
impaired cardiac metabolic gene expression
impaired lv relaxation
impaired systolic function
implantable cardioverter defibrillator-crt
implantable cardioverter-defibrillator deactivation
implantable cardioverter-defibrillator deactivation preferences
implantable cardioverter-defibrillator device
implantable cardioverter-defibrillator therapy
implanted left-to-right interatrial shunt
implanted monitoring devices
in vivo inhibition
in-hospital adverse events
inactive
inappropriate shock therapy
inappropriate therapy
incessant ventricular tachycardia storm
incidence and mortality outcomes
incidence of and deaths
incident
incident cardiovascular events
incident hf
income
incubation of ec
index admission
index ami
index beat method
index ed
index hf
induce heart failure
induced
induced myocardial infarction
induced pluripotent stem cell-derived cardiomyocytes
inducible myocardial ischemia
inducing hyperkalemia
induction
industrial areas
infarcted hearts
infarcted left ventricle
infarcted rats
infarction-related refractory right heart failure
inflammation-stimulated resistin
inflammatory abdominal problems
inflammatory biomarkers
inflammatory markers
inflammatory stimuli
influx
inhibition
inhibition of protein kinase
inhibition of vascular endothelial growth factor
inhibitor jq1
inhibitors
inhibitory actions
inhospital mortality
inhospital outcomes
inotrope-dependent
inpatient admissions
inpatient data
inpatient records
instability
insulin action
insulin receptor substrates
insulin-signaling
insulin-stimulated rates
insurance status
intact hearts
interconnected molecular pathways
interleukin receptor family
intermediate care
intermediate frail
intermediate frailty
intermediate metabolism
intermediate odds ratios
intermuscular fat ratio
internal consistency
internal reliability
interventricular septum biopsies
intestinal morphology
intl
intracellular antiadrenergic therapeutic strategy
intravenous atropine
intravenous bolus of metoprolol
intravenous inotropes
intravenous iron
intravenous metoprolol
intrinsic left ventricular dysfunction
intubation rates
invasive hemodynamic
ip
iron
iron deficiency
iron-deficient adult patients
irr2
irr2 proteins
irrael
ischemic etiology
ischemic hf pathogenesis
isolated cardiomyocytes
isolated heart rate
isolated heart transplant
isolated heartmate ii
isolated heartmate ii lvad
isolated hr reduction
isolated lvad
isolated myoctyes
isolated pump replacement
isoprenaline infusion
iv hf
ivabradine group
ivabradine unloads
ivabradine-treated
japanese heart failure
jehovah
joint associations
joint effect
kaiser permanente northern california
kaplan-meier
kccq scales
kd
kidney index
kidney index score
kir
kv4.3 mrna levels
kvq
l-dco mice
l-type ca2
l-type channel inhibition
l-type channel isoforms
l-type channel-dependent processes
label-free shotgun proteomics
laboratory report
lancet
late-activated lateral wall
late-onset
late-onset hf
lb
lbb
lc-ms
lead
leaflet motion
leaflet repair
leaflet resection
lean body mass ratio
lean zsf1
lean zsf1 group
left
left main
left ventricular assist device implantation
left ventricular biopsies
left ventricular filling pressure response
left ventricular function assessment
left ventricular longitudinal systolic strain
left ventricular mechanics
left ventricular midpapillary
left ventricular systolic
left ventricular tissue
left-hand grip strength
left-to-right interatrial shunting
leg strength
legal majority
length-force relationship
leu3-gly4
lf
liberal transfusion protocols
life-sustaining treatment
lipid-lowering therapy
littermate controls
liver-specific irs1
load-corrected chronotropic response
log
log2
logistic regression models
lokomat® system
long-acting insulin
long-term mortality
long-term ventricular assist device
longitudinal change
low bp
low left ventricular ejection fraction
low pasp
low testosterone status
low-dose bb
low-dose dopamine
low-dose nesiritide
low-frequency
low-sodium dash
low-volume ed cases
low-volume eds
low-volume hospitals
lower limbs
lu27
lu27 haplotype
lung weight
lv contractil
lv end systolic volume index
lv systolic indices
lvad implantation
lvad surgery
lying
m7
mad-crt
madit-crt trial
magnetically levitated centrifugal-flow chronic lvas
magnetically levitated left ventricular assist system
magnetically levitated rotor
main outcome
maladaptive cardiac remodelling
maladaptive remodelling
malignancies
malondialdehyde bound
mammalian
markers
markers of hemostasis
masked outcome assessments
mass
mass spectrometric
md
mean ejection fraction
mean pressure gradient
mechanical
mechanical cardiac
mechanical dyssynchrony
mechanical support devices
mechanism
mechanism of action
mechanism of cardioprotection
mechanisms
mechanisms of disease
medical center
medical conditions
medical hospitalization
medical records
medical staff
medical therapies
medical treatment guidelines
medically managed diseases
medicare coverage
medication lists
medication regimen
mediterranean
mediterranean and dietary approaches to stop hypertension
mediterranean diet score
mediterranean diet scores
mena levels
mesenchymal transition markers
metabolic abnormalities
metabolic changes
metabolic enzymes
metabolic risk factors
metric
mi-induced decreases
mice
midwestern state
migration
mild patients hospitalization
mineralocortic receptor antagonists
mineralotic receptor antagonists
minnesota living
minnesota living with heart failure
mir-25 expression
mistargeting
mitochondrial complex
mitochondrial damage induced
mitochondrial dysfunction induced
mitochondrial oxidative stress induced
mitochondrial proteome changes
mitochondrial ultrastructural changes
mitochondrial-targeted antioxidant
mitochondrial-targeted peptide drugs
mitochondrial-targeted peptide ss31
mitral e/e
mitral leaflet
mitral stenosis reversed
mlhf
molecular biomarkers
molecular mechanism
monitoring board
morpholino-based knockdown
mortality predictors
mortality rate
mortality rates
mortality risk
mouse
mouse heart
mouse heart failure
mouse hearts
mouse rad q65p
mouse tac model
mouse ventricular myocytes
mri-based models
mrna levels
msms
mt
mt group
multicenter automatic defibrillator implantation
multiparametric echocardiographic score
murine equivalent
murine myocardium
murine resistin
muscle function
muscle strength
muscle strip stiffness
muscle strips
muscle wasting
muscle-wasting syndrome
muscular strength
mutant
mv
mwt
myocardial delayed enhancement imaging
myocardial extracellular matrix accumulation
myocardial glycolysis
myocardial infarction-both
myocardial loss
myocardial pde2
myocardial pde2 expression
myocardial phosphodiesterase-2
myocardial titin hypophosphorylation
myocyte diameter
myocyte hypertrophy antecedent to heart failure
myofiber shortening onset
myofiber shortening velocity
myosin binding protein-c phosphorylation
n-terminal fragment
n-terminal pro-brain-type natriuretic peptide assessment
na+ channel mrna splice
na+ current
nad(p-oxide subunit rac2
nafat
nanomolar doses
nari
national cardiovascular disease registry
natriuretic peptide levels
natriuretic peptide system
natural vasodilatory
ncd pinnacle
nef-inv rabbits
negative coronary angiography
neonatal rat
neprilysin blocks
neprilysin inhibitor prodrug
nesiritide strategy
neurohormonal abnormalities
neurohormonally induced heart disease
neutral endopeptidase inhibitors
new-onset esrd
nfat signalling
nicorandil ameliorates mitochondrial dysfunction
ninth revision
nitric oxide donors
non-aas
non-biological disease
non-diabetic patients
non-diastolic abnormalities
non-dnx
non-fatal stroke
non-frail
non-hf
non-ischemic
non-lbb
non-linear hr variability measures
nonadherence
noncardiac
noncardiologist
noncardiovascular diagnoses
noncardiovascular drugs
noncoding rnas
nondiabetes risk factors
nonfunctional channels
nonglycosylated
nonmitochondrial protein changes
nonpace
nonpace dnx
nonsurvivors
nontrastuzumab
nontraumatic death
nordic walking
norepinephrine-induced hypertrophic responses
normal albumin
normal geometry
northwest united states
np assessment
np levels
np measurement
np-terminal pro-b-type natriuretic peptide
np-terminal probnp
nrt00180271)
nt-probnp assay
nt-probnp cutoff point
nt-probnp levels
nt-probnp testing
nursing care
nursing terminologies
nursing-sensitive outcome measures
nutrition
nutritional
nutritional abnormalities
nuts
nyha ii-iii
o-1 signaling
o2
obese body mass index
obese zsf1
obese zsf1 groups
odds of dying
off-pump
office hours
office of statewide health planning and development patient discharge
oht bridged
older adults
onset af
onset heart failure
onset of heart failure
open
open chest model
open stent
open surgery
operating characteristic curve
oral glucocorticoid
oral glucocorticoids
organic lesion
organisation of care taxonomy
oscillatory ventilation
ot
outcome change scores
outcome ratings
outcome-monitoring phase
outline
outpatient assessments
outpatient settings
overweight
oxidative stress markers
oxygen consumption
oxygen flow
oxygen pulse
p38alpha mapk
p70s6k-ser
pace
pace non-dnx
paced myocardium
paediatric cardiac transplants
paediatric heart failure
parasympathetic function
parasympatic neurotransmission
pasp relationship
passive
patent
pathological cardiac gene expression programme
pathological changes
pathological gene expression
pathological gene induction
pathological heart disease
pathological hypertrophy
pathological remodelling
pathological stress
pathophysiologic mechanism
pathophysiologic mechanisms
pathophysiologic state
pathophysiological origin
pathway alterations
pathway analysis
patient management interventions
patient safety
pay-for-performance
pb cycle
pcp
pde superfamily
pde2 activity
pde2 expression
pde2 overexpression
peak o2 per kilogram
peak respiratory
pediatric heart failure
pediatrics
penalties
percutaneous coronary revascularization
percutaneous one-vessel model
peripheral abnormalities
perk activation
perk inhibition
permanent periodic breathing
permeability
persistent persistent af
perturbed mitochondrial function
pf cohort
pf-cp
pg
pharmacologic therapies
pharmacologic treatment
pharmacological armamentarium
phenylephrine-induced genes
phosphomimic ser77
physical activity
physical exertion
physician adherence
physician continuity
physio ring
physiological proteolysis
pif-acetylhydrolase
pigs
pkc-βii-ser
plasma collected
plasma samples
plasticity
plateau phase
pluripotency marker nanog
poc measurement
point-of-care systems
policy
polytetrafluoroethylene tube
porcine model
positron emission tomography imaging
post myocardial infarction
post-aac
post-acute care transfer policy
post-dash
post-hct chf
post-myocardial infarction heart
post-tac
post-translational states
post-transplant morbidity
post-transplant mortality
posterior wall thickness
postmarketing trials
postmenopausal women
postnatal mammalian myocardium
postoperative echocardiography
postoperative months
postoperative mortality
postoperative normalization
postoperative survival
power spectral
power systems
pp
practice
practice innovation and clinical excellence
practice-level variation
pre-crt
pre-hct
pre-hct germline dna
pre-pd
precipitating factor
prediction rule
predictor
predictors of mortality
preferences
preoperative albumin
preoperative hypoalbuminemia
preoperative renal dysfunction
preoperative serum albumin levels
prescribed therapy
pressure
pressure-overload-induced hypertrophy
pressure-volume conductance
primary care clinicians
primary end point of all-cause mortality
primary isolated cab
primary isolated cabg
primary oscillations
primary outcome of death
principal discharge diagnosis
principal mechanisms
prior stroke score
pro2-leu3
pro6-gly7
pro75-arg76
proangiogenic effects
procedure
process
production
prognostic power
programmed cell death
progression
progressive disease
prolonged electromechanical delay
prone
proof-of-principle
propensity
propensity score decile
prostate
protective peptides
protein levels
protocol-driven poc testing
proximal circumflex artery
proximal lad
proximal left anterior descending artery
pss
psychometric profile
psychometric testing
psychosocial factors
public health
public reporting
publicly
pulmonary arterial systolic pressure relationship
pulmonary artery snared
pulse-wave velocity
pump
pump exchanges
pump failure
pump malfunctions
pump replacement
pump-exchange technique
pure epicatechin
pyridostigmine administration
qt
quality-of-life score
quartiles
quintiles
r-r interval oscillations
rabbits
race
race by treatment interaction
rad q65p
rad q66p
radial artery tonometry
radioenzymatic
raf-mek1/2-erk1/2
raised blood glucose levels
raloxifene-treated
randomized trials
ras-
ras-blocker uptitration
rat metabolic risk model
rate of death
ratio
ratio of phosphocreatine
ratio of systolic blood pressure
ratios
rats
readmission metric
readmission metrics
readmission rate
readmission rates
readmission reduction program
receiver operating characteristic curve
receptor antagonist
reciprocal downregulation
reciprocal regulation
recommended therapies registry
recovery
recovery period
recreational athletes
red blood cell transfusion strategy
redued ejection fraction
refractory
regulate expression
regulates cardiac sodium current
regulates ventricular action potential duration
regulation
regulation of feeding
regulator
regulator of growth
regulatory
regulatory subunit
relative appendicular lean mass index
relative minimal detectable change
relative value
relaxation
religious beliefs
renal atherosclerotic lesions
renin- angion-aldosterone pathway
renin-angioten-aldosteron
renin-angioten-aldosterone system inhibitors
reperfusion therapy
repolarization lability
report
report model
reporting
residual confounding
resistance training
respiratory gas
resynchronization reverses remodeling
resynchronization-defibrillation
retn gene
reversal of changes
reversal of detrimental alterations
reverse cardiac remodeling
reverse remodeling parameters
reversibility
reversible
reversible causes
reversible myocardial ischemia
reviews and dissemination
rg
rhythm
rhythm- and rate-control
right atrial area
right atrial mass removal
right atrium mass
right grip strength
right ventricle overload leads
right ventricular contractil
right ventricular contractil reserve
right ventricular fractional area change
right ventricular pump
risk
risk factors
risk model
risk of death
riα proteins
rna polymerase ii
robot-assisted gait therapy
robot-assisted training
ronbach
rotterdam
rovad
rr intervals
rule
rv failure management
s'lateral
s'septal
s1p1
s1pr
s2
salt
salt intake
sarcomeric
sarcopenic range
scaffold protein drives
schf
schfi
sci
science
scn5a transcript
sdqt-to-sdrr ratio
seattle heart failure model-predicted survival
secondary outcome of death
self-care
self-care education
self-care management scale
self-care of heart failure index
self-management counseling
self-reported physical activity
septal defects
septal wall
sequential phosphorylation
ser23/24 troponin i phosphorylation
ser80
ser96)
serum factors
serum levels
serum resistin levels
serum sodium levels
sex
sex differences
sham
sham group
sham levels
sham-innervated
sham-inv
sham-nx
sham-operated
sham-operated animals
shams
sheet orientation
short physical performance battery
short-form quality of life
short-term mortality rates
shortened lvet
shortness of breath due to lung congestion
shotgun
shunt implantation
shunt implants
signal transduction cascade
signaling
signaling paradigms
signalling cascades
signalosome
signed-rank tests
skeletal muscle abnormalities
skeletal muscle mass
skeletal muscle sarcomere
skinfold thickness
smad
small-molecule inhibitors
smoked
smoking
smoking cessation
sn5a
snared
social
social mandate
social support
social support score
society
socioeconomic
sodium-restricted dash diet
sodium-restricted dietary
soluble guanylate cyclase
soluble st2
southeastern minnesota
sphingosine-1-phosphate receptor
spironolactone dose
spontaneous cardiac dysfunction
sport
sprague-dawley rats
sr ca(2+)-pump function
srd
sst2 measurement
st2 levels
stable coronary artery disease
stand-alone diagnostic devices
standard cardiac rehabilitation care
standard heart failure medicines
standard practice
standing blood pressure
statitistical
stem cell source
stent coated
stent occlusion
sternal sparing
stiffness
stockholm
stockholm national inpatient registry
stop hypertension diet
strain rate
stress conditions
stretch rate
stroke prevention trial
structural heart disease
structurally normal hearts
sts hh
sts hm
subcellular alterations
subclinical atherosclerosis
subunit expression
sudden cardiac death
sudden cardiac deaths
sudden death
surgical indication
surgical method
surgical patients
surgical revascularization
surgical ring implantation
surgical tactics
survival
survival projections
survival study
svr index
swedish web-system for enhancement and development of evidence-based care
swine
swine model
sympathetic control
symptom domains
systolic heart failure treatment
systolic left v entricular dysfunction
t test
t1-mapping sequence
t1-mapping technique
tac-induced proteomic alterations
tachy-
tachycardia-induced heart failure
tachycardic response
tapse-to-pasp ratio
target sodium
taxonomy
technical advisors
technology
telehealth system
term
termini
testosterone group
testosterone levels
tests
texas cancer registry-medicare
tg
tg-β inhibition
tg-β receptor
tg-β signaling
tgtetmena
tgttmena mice
tgtttmena mice
tgttttmena
thalassaemia
therapeutic interruption
therapeutic potential
therapy refractory cardiogenic shock
thickness
thigh muscle
time up & go test
timed up and go
tissue
tissue doppler imaging
tissuefaxs technology
titin isoforms
titin modification
tobacco
tonometric indices
total cholesterol
toxicity
tpse
training-induced changes
trans
transcription
transcription factors driving
transcriptional
transforming growth factor
transfusion thresholds
transgenic mice
transient
transient receptor potential cation channel
transition
transitions of care
transmitral e-wave
transmitral flow velocities
transplant pool
transplant-ineligible patients
transplantation eligibility status
trapped
trastuzumab administration
trastuzumab-related cardiotoxicity
trastuzumab-related chf
trastuzumab-treated patients
trastuzumb-related chf
treadmill exercise testing
treadmill testing
treatating advanced hf
treatment
treatment algorithms
treatment for heart failure
treatment group effects
treatments
trial
trial-cardiac resynchronization therapy
trials
trichrome blue
trigger
trigger hemoglobin threshold
trp7)
truncated
truncated na+ channels
tta
tunel assay
tunel method
turbulence
twist
two-vessel disease model
u.s. food and drug administration
ultrastructural
ultrastructural changes
um
um/va
unanchors
unclear etiology
uncontrolled hypertension
underlying heart disease
undiagnosed heart disease
unfit
unintentional weight loss
unloading of the heart
unplanned readmission
untreated acf groups
upr effectors
upstream signal
urgent all-cause readmission
urgent cardiac transplant
urgent readmission
usual care
uv treatment
va
va-rt
va-rt cohort
vad group
vad groups
vagal
vasodilator effects
vasopressin receptor antagonist therapy
vco2 slope
veg
vegetables
vegfr2
vehicle
vehicle-treated rats
velocity
velocity time
ven
venous thrombolic events
ventricular power index
ventricular wall stress
ventricularly paced
vessel
vet
viscoelastic
vivo phosphorylation sites
voltage-gated
voltage-gated cardiac na+ channel
von wilebrand factor
waist circumference
walk distance
walk test
walk test distance
walking distance
wasting
wasting of fat
wave doppler echocardiography
wave ratio
waves
weak grip strength
weight
weight loss
white
white rabbits
whole grain intake
wilcoxon
wild type
wild-type littermates
wistar rats
withdrawal of sympathetic tone
witness
women
working hearts
workload
wrf
wt riα
x-ray absorptiometry
xanthine oxide inhibition
yielded hazard ratios
yorkshire swine
zebrafish
zf1 groups
zf1 rats
zung
β-adrenergic receptor activation
β-adrenergic receptor haplotype
β-adrenergic receptor stimulation
β-ar drive
β-ar stimulation
β-blocker dose
β-blocker dose changes
β-blocker uptitration
β-blocker uptitrations
β-blocker-induced enhancement of cardiac angiogenesis
β-blockers therapy
β1ar downregulation
β1ar overstimulation
β2-receptor haplotype status
β2receptor
